Table 1 General population characteristics
Median / frequency | |
|---|---|
Age in years [IQR] | 66 [57–75] |
Male (%) | 146 (59.6) |
Type of Cancer | |
Solid tumor (%) | 195 (79.6) |
Hematologic malignancy (%) | 48 (19.6) |
Unknown origin (%) | 2 (0.8) |
Vital signs | |
Pulse rate per minute [IQR] | 112 [94–128] |
Respiratory rate per minute [IQR] | 24 [20–30] |
Pulse oximetry in % [IQR] | 90.5 [85.0–95.0] |
Systolic BP in mmHg [IQR] | 115 [101–134] |
Diastolic BP in mmHg [IQR] | 70 [61–81] |
Body temperature in Celsius [IQR] | 37.2 [36.6–38.2] |
PPS within 24 h of admission | |
PPS 100 (%) | 0 (0.0) |
PPS 80–90 (%) | 15 (6.4) |
PPS 60–70 (%) | 103 (43.8) |
PPS 40–50 (%) | 78 (33.2) |
PPS ≤ 30 (%) | 39 (16.6) |
Laboratory | |
Hematocrit in % [IQR] | 30.9 [27.0-35.8] |
WBC per mm 3 [IQR] | 11,600 [7,800 − 17,800] |
Percentage of lymphocytes [IQR] | 8.0 [5.1–14.6] |
Serum sodium in mEq/L [IQR] | 133 [129–136] |
Serum glucose in mg/dL [IQR] | 121 [102.5-157.5] |
BUN in mg/dL [IQR] | 17.0 [11.0–26.0] |
Comorbidities | |
Congestive heart failure (%) | 2 (0.8) |
Cerebrovascular disease (%) | 7 (2.9) |
Renal disease (%) | 16 (6.5) |
Liver disease (%) | 8 (3.3) |
Treatment history | |
Received chemotherapy within 4 weeks (%) | 50 (20.4) |
Received chest radiation therapy within 4 weeks (%) | 1 (0.4) |